SR Merck Gardasil

REVUE DE PRESSE / PRESS CLIPPINGS
GARDASIL
Thursday, February 25, 2010
Media Clippings · Special Edition

2.25.2010
TABLE OF CONTENTS
NEWS.................................................................................................................................................................. 3
Newspapers...................................................................................................................................3
Telegraph-Journal (NB) / Feb. 25 / D4 / HPV vaccine approved for males aged 9 to 26 in Canada .... 3
The Daily News (Kamloops) / Feb. 24 / 23 / HPV vaccine for genital warts approved for Canada's
males ...................................................................................................................................................... 4
Times-Herald (Moose Jaw) / Feb. 24 / B8 / HPV vaccine approved for males aged nine to 26 in
Canada ................................................................................................................................................... 5
Internet...........................................................................................................................................6
Thestar.com / Feb. 24 / online / HPV vaccine to prevent genital warts approved for males aged 9 to
26............................................................................................................................................................ 6
Healthzone.ca / Feb. 24 / online / HPV vaccine to prevent genital warts approved for males aged 9 to
26............................................................................................................................................................ 7
Also published in: telegraphjournal.canadaeast.com; cjob.com; .640toronto.com ...................................................................7
Financialpost.com / Feb. 24 / online / HPV vaccine for males approved............................................... 8
Medicalnewsbase.com / Feb. 23 / online / Health Canada approves GARDASIL for prevention of
genital warts in males............................................................................................................................. 9
Longplainfirstnation.ca / Feb. 23 / online / Gardasil approved for males............................................. 11
Medbroadcast.blogspot.com / Feb. 24 / online / HPV vaccine to prevent genital warts approved for
males aged 9 to 26 in Canada ............................................................................................................. 11
Links.gocom.ca / Feb. 24 / online / HPV vaccine approved for young males in Canada .................... 11
Bloggingcanadians.ca / Feb. 24 / online / Gardasil approved for males.............................................. 11
Lifesitenews.com / Feb. 24 / online / Health Canada Approves Controversial HPV Vaccine For Males
.............................................................................................................................................................. 12
Also published in: deadlinelive.info .........................................................................................................................................12
RTV...............................................................................................................................................13

2.25.2010
NEWS
Newspapers
Telegraph-Journal (NB) / Feb. 25 / D4 / HPV vaccine approved for males aged 9 to 26

in Canada
The Canadian Press
The vaccine manufacturer Merck says Health Canada has approved Gardasil for the prevention of genital
warts caused by HPV infection in boys and men aged nine to 26.
HPV, or human papillomavirus, is the most common sexually transmitted infection and can also cause anal
cancer in men.
Gardasil has already been approved for females aged nine to 26 in Canada to prevent cervical cancer and
genital warts.
The vaccine is designed to prevent infection by four of the most common strains of the virus.
Merck says most genital warts are caused by two HPV strains, which are both targeted by the vaccine.
An estimated 40,000 new cases of genital warts are diagnosed each year in Canadian men and women.
© 2010 Telegraph-Journal (NB). All rights reserved.

2.25.2010
The Daily News (Kamloops) / Feb. 24 / 23 / HPV vaccine for genital warts approved
for Canada's males
Column: Canada Today
Source: Canadian Press
cancer in men.
genital warts.
Merck says most genital warts are caused by two HPV strains, which are both targeted by the vaccine. An
estimated 40,000 new cases of genital warts are diagnosed each year in Canadian men and women.
© 2010 The Daily News (Kamloops)

2.25.2010
Times-Herald (Moose Jaw) / Feb. 24 / B8 / HPV vaccine approved for males aged nine
to 26 in Canada
The Canadian Press
TORONTO - The vaccine manufacturer Merck says Health Canada has approved Gardasil for the
prevention of genital warts caused by HPV infection in boys and men aged nine to 26.
cancer in men.
genital warts. The vaccine is designed to prevent infection by four of the most common strains of the virus.
© 2010 Times-Herald (Moose Jaw). All rights reserved.

2.25.2010
Internet
Thestar.com / Feb. 24 / online / HPV vaccine to prevent genital warts approved for
males aged 9 to 26
The Canadian Press
cancer in men.
genital warts.

2.25.2010
Healthzone.ca / Feb. 24 / online / HPV vaccine to prevent genital warts approved for
males aged 9 to 26
Also published in: telegraphjournal.canadaeast.com; cjob.com; .640toronto.com
The Canadian Press
cancer in men.
genital warts.

2.25.2010
Financialpost.com / Feb. 24 / online / HPV vaccine for males approved
Canwest News Service
Health Canada has approved the use of a vaccine for boys and young men to protect them against the
human papilloma virus and genital warts, pharmaceutical company Merck Frosst announced yesterday. The
vaccine, Gardasil, was first approved by Health Canada in July 2006 for females between ages nine and 26,
the same age group targeted for males. HPV is the most common sexually transmitted infection in Canada.
More than 40,000 new cases of genital warts are estimated annually for both sexes in Canada.

2.25.2010
Medicalnewsbase.com / Feb. 23 / online / Health Canada approves GARDASIL for
prevention of genital warts in males
Today, Merck announced that Health Canada has approved GARDASIL(R) (Human papillomavirus
Quadrivalent (Types 6, 11, 16, and 18) Recombinant Vaccine) for boys and men nine through 26 years of age
for the prevention of infection caused by HPV types 6, 11, 16, and 18 and genital warts caused by HPV
types 6 and 11.
"I see a large number of men with genital warts which are both difficult and painful to treat," said Dr. Charles
Lynde, a practising Dermatologist and Assistant Clinical Professor, University of Toronto. "We have many
treatments for genital warts which are often not all that effective. With Health Canada's approval of the use
of Merck's vaccine in males, now rather than treating them after the fact, the prevention of warts for both
sexes is possible in this country."
"Often genital warts are imperceptible for many months, making it difficult for partners to see them," said Dr.
Marni Wiseman, a Dermatologist and Assistant Professor at the University of Manitoba. "Once out in the
open, genital warts can have a major impact on a couple's sexual relationship."
"Sophisticated research has shown viral DNA in the skin cells of young women at the location of genital
warts after the warts have been destroyed and no longer visible," said Dr. Kirk Barber, a practising
Dermatologist and Associate Clinical Professor of Dermatology at the University of Calgary. "I suspect that
this is the reason that recurrence rates are so high in both young women and men."
"Social stigma is associated with all sexually transmitted diseases and genital warts is no exception," said
Dr. Marc Steben, a Canadian expert in sexually transmitted infections.
"You feel invincible when you're young and getting genital warts has affected me. I kept to myself and I didn't
date a lot after that. I am not at all comfortable talking about genital warts with friends, family, partners,"
admitted a young man who has been living with genital warts for 10 years.
HPV is the most common sexually transmitted infection in Canada and genital warts are common among
males. Most (90 per cent) genital warts are caused by HPV types 6 and 11; more than 40,000 new cases of
ano-genital warts are estimated yearly for Canadian men and women.
High level of shared HPV infections

In a Canadian study recently published in Sexually Transmitted Diseases more than half (56 per cent) of
young people in a new sexual relationship were infected by HPV. Those infected were, on average, infected
with 2.8 types of HPV.
Men play an important role in the transmission of HPV to their sexual partners. Research has shown a high
level of sharing of HPV infections between couples who recently became infected.
The data consistently support the sexually transmitted nature of HPV and the role of men in infecting women,
who subsequently can develop HPV-related ano-genital cancers and genital warts. Based on these various
lines of evidence it is expected that decreasing the risk of HPV infection in men through vaccination should
decrease the risk of infection in their sexual partners, thereby providing additional public health benefit.
Significant decline in genital warts

In the Phase III clinical study conducted over three years with more than 4,000 males ages 16 to 26, the
quadrivalent HPV vaccine was 89.4 per cent efficacious in reducing the incidence of genital warts related to
HPV types 6 and 11 among males who were naïve to HPV types 6, 11, 16, and 18.
A separate Australian retrospective study to assess the impact of the national vaccination program with the
quadrivalent HPV vaccine on females showed early benefits from vaccination. The study found a significant

2.25.2010
decline in genital warts cases in the targeted female population as well as a drop in genital warts among
heterosexual but not homosexual men.
GARDASIL(R) is also indicated in girls and women nine through 26 years of age for the prevention of
infection caused by the human papillomavirus (HPV) types 6, 11, 16, and 18 and the following diseases
associated with these HPV types:
● Cervical cancer (cancer of the lower end of the uterus or womb)

● Vulvar (the outside of the female genital area) and vaginal cancers
● Genital warts (condyloma acuminata)
● Cervical adenocarcinoma in situ (AIS) - non invasive cancer
● Cervical intraepithelial neoplasia (CIN) grade 2 and grade 3 (changes in cells of the cervix that have a risk
of turning into cancer) - commonly called pre-cancers
● Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3 (abnormal lesions on the outside of the female
genitalia that have a risk of turning into cancer) - commonly called pre-cancers
● Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3 (abnormal lesions on the vagina that have a
risk of turning into cancer) - commonly called pre-cancers
● Cervical intraepithelial neoplasia (CIN) grade 1 (changes in cells of the cervix that often clear up on their
own) - commonly called low- grade lesions
Source: MERCK

2.25.2010
Longplainfirstnation.ca / Feb. 23 / online / Gardasil approved for males
Gardasil, a vaccine against human papilloma virus (HPV), has been approved as a treatment to prevent
genital warts in males aged nine to 26 in Canada, the vaccine's manufacturer said Tuesday.
With a link to:

www.cbc.ca/health/story/2010/02/23/HPV-Gardasil-males.html?ref=rss
Medbroadcast.blogspot.com / Feb. 24 / online / HPV vaccine to prevent genital warts

approved for males aged 9 to 26 in Canada
TORONTO - The vaccine manufacturer Merck says Health Canada has approved Gardasil for the
prevention of genital warts caused by HPV infection in boys and men aged nine to 26....More
With a link to:

www.medbroadcast.com/channel_health_news_details.asp?news_id=20652&rss=67&channel_id=1039&rot=
3
Links.gocom.ca / Feb. 24 / online / HPV vaccine approved for young males in Canada
Gardasil, one of the HPV vaccines available in Canada, has now been approved by Health Canada for use
in boys and men.
With a link to:

http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20100223/Gardasil_men_110223/20100223?hub=Heal
th&s_name=
Bloggingcanadians.ca / Feb. 24 / online / Gardasil approved for males

The big test: will it make money? Yup. APPROVED
With a link to: http://www.cbc.ca/health/story/2010/02/23/HPV-Gardasil-males.html

2.25.2010
Lifesitenews.com / Feb. 24 / online / Health Canada Approves Controversial HPV
Vaccine For Males
Also published in: deadlinelive.info
By Thaddeus M. Baklinski
OTTAWA, February 24, 2010 (LifeSiteNews.com) - Vaccine manufacturer Merck Frosst Pharmaceutical
announced yesterday that they have approval from Health Canada for the use of the human papilloma virus
(HPV) vaccine Gardasil in boys and young men.
HPV is the most common sexually transmitted disease in the world, though, according to the World Health
Organization (WHO), few people who have contracted the infection ever experience symptoms.
Gardasil was approved by Health Canada in 2006 for females between the ages of nine and 26, with the
goal of preventing cervical cancer and genital warts. In males the same age group is targeted, with the
intent of combating genital warts and anal cancer.
The U.S. government watchdog agency Judicial Watch, which has tracked the use of the vaccine since it was
approved by the FDA, has repeatedly raised concerns over the safety of Gardasil and questions both the
safety and usefulness of administering the vaccine to males.
"HPV can lead to cervical cancer in women, but in men the most common complaint is genital warts.
Although genital warts are contagious and can cause discomfort and embarrassment, they are usually not
serious," a report from Judicial Watch states.
"Also, according to a briefing document provided to the Vaccines and Related Biological Products Advisory
Committee (VRBPAC), only ‘~1% of all sexually active adults in the U.S.’ has genital warts. Given the
extremely low number of males who experience complications from HPV, it is worth questioning whether the
vaccine is necessary for males at all." Judicial Watch also notes that "the VRBPAC briefing document shows
that Gardasil is only 67.2% effective for men, and for men who have been exposed to HPV, the efficacy rate
is only 23.2%."
Commenting on the unresolved benefit of Gardasil immunization, Dr. François Coutlée, a clinical researcher
at the Molecular Virology Laboratory, CHUM - Hôpital Notre-Dame, who has been researching the use of
Gardasil in men, told CTV.ca that most people who get genital warts will eventually fight off the infection
without medical intervention.
"For most individuals who develop genital warts, it's just a matter of time when their bodies will fight it off. It
can take six months, two years, three years," Dr. Coutlée said. "But for 95 per cent of individuals, the immune
system will fight off the infection."
Dr. Coutlée also noted that those who have successfully fought off infection with one strain of HPV can still be
infected again by another strain. "Infection with multiple types at the same time is a possibility," he said. "Even
if you've been infected with one type doesn't mean you can't be infected by another type. And there are about
40 genital types around. So lots of genital types."
According to Merck, Gardasil is designed to affect only four of the more than 100 strains of HPV. In addition,
the vaccine has already proven to be extremely dangerous to girls and women. According to the FDA's
Clinical Review, released in September 2008, 85.9% of girls aged 9 -17 experienced adverse events after
receiving the Gardasil vaccine, while 92.5% of women aged 18 - 26 experience adverse events. The report
also found that "there was only an 18.4%...reduction of any HPV related lesions (that could lead to cervical
cancer) in the entire study population."
Judicial Watch reports that in the period between May and September 2009, Gardasil vaccinations resulted
in 1,510 adverse event reports being filed, of which 19% were classified as "serious", 40 cases were life
threatening, 77 cases resulted in permanent disability, and 8 deaths were reported, making the total number
of deaths connected to Gardasil vaccinations 55.

2.25.2010
RTV
Gardasil is the vaccine against the HPV virus

Program: Afternoon Edition Air Time: 3:00PM - 4:00PM Date: 2010-Feb-24
3:43PM
Station: CFRA AM Network: CFRA Division of CHUM City: Ottawa
Ltd.
Reporter: Rob Snow Length: 06:00 Province: Ontario
Interview: Dr. Barry Dworkin
Note: It has now been approved as a treatment to prevent genital warts in men aged 9 to 26 in
Canada. Tag: Sexually Transmitted Diseases Journal, Cervical Cancer, Health Canada,
H1N1.
Log ID: 20100224R-2175
Health Canada has approved Gardasil for males in the prevention of genital warts
Program: CTV News Air Time: 11:30PM - 12:00AM Date: 2010-Feb-23
Tonight 11:49PM
Station: CTV News Network: CTV Inc/Bell Globemedia City: Toronto
Channel Inc
Reporter: Marcia Length: 00:30 Province: Ontario
MacMillan
Interview: None
Note: tag: Health Canada, Gardasil, h.p.v vaccine, males, age 9 to 26, genital warts
Log ID: 20100224T-0134
Health Canada has approved an h.p.v. vaccine for males in the prevention of genital warts
Program: CTV News Air Time: 10:30PM - 11:00PM Date: 2010-Feb-23
Tonight 10:48PM
Channel Inc
MacMillan
Interview: None
Note: Health Canada, h.p.v. vaccine, Gardasil, males, age 9 to 26, genital warts
Log ID: 20100224T-0128

2.25.2010
A vaccine that protects women from cervical cancer can now be used by boys and men to
prevent genital warts
Program: Power Play Air Time: 8:00PM - 9:00PM Date: 2010-Feb-23
8:46PM
Channel Inc
MacMillan
Interview: Dr. Charles Lind, Dermatologist, and Professor, University of Toronto
Note: tag: vaccine, Gardasil, women, boys, age 9 to 26, cervical cancer, Health Canada,
2008, Ottawa, program, girls, h.p.v virus
Log ID: 20100224T-0172
Boys and young men in Canada will now be able to roll up their sleeves to get vaccinated for
the virus that causes cervical cancer in women
Program: Up to Speed Air Time: 3:00PM - 6:00PM Date: 2010-Feb-23
5:13PM
Station: CBC Radio 1 Network: Canadian Broadcasting City: Winnipeg
(Winnipeg) Corporation
Reporter: Margaux Watt Length: 06:30 Province: Manitoba
Interview: Dr. Joel Kettner, Manitoba Chief Medical Officer;
Note: Today, Health Canada approved the use of the drug Gardasil for boys as young as nine
years old. TAG: HPV Vaccination Provincial Program,
Log ID: 20100224R-0191
The vaccine manufacturer Merck says Health Canada has approved an HPV vaccine for boys
and men aged 9-26
Program: CH News Now Air Time: 2:00PM - 5:00PM Date: 2010-Feb-23
3:06PM
Station: CHCH TV Network: Channel Zero City: Hamilton
Reporter: Taz Boga Length: 00:30 Province: Ontario
Interview: None
Note: Gardasil has already been approved for females in that age bracket to prevent cervical
cancer and genital warts. Tag: Human Papilloma Virus, anal cancer in men, sexual
transmitted infection, Canadian
Log ID: 20100224T-0072

2.25.2010
Health Canada has approved a vaccine used to protect women from cervical cancer to be used
to prevent genital warts in boys and men
Program: Power Play Air Time: 8:00PM - 9:00PM Date: 2010-Feb-23
8:16PM
Channel Inc
MacMillan
Interview: Dr. Charles Lind, Dermatologist, and Professor, University of Toronto
Note: tag: Health Canada, Gardasil, women, cervical cancer, genital warts, boys, ages 9 to
26, men
Log ID: 20100224T-0178
Health Canada has approved Gardasil in the prevention against genital warts for men and
boys
Tonight 7:49PM
Channel Inc
MacMillan
Interview: None
Note: tag: vaccine, women, cervical cancer, Health Canada, Gardasil, genital warts, men,
boys, ages 9 to 26, Ottawa, program, girls, h.p.v. virus
Log ID: 20100224T-0177
A vaccine that protects women from cervical cancer can now be used by boys and men to
Tonight 7:19PM
Channel Inc
MacMillan
Interview: None
Note: tag: vaccine, women, cervical cancer, boys, men, genital warts, Health Canada,
Gardasil, males, ages 9 to 26, 2008, Ottawa, program, girls, h.p.v. virus
Log ID: 20100224T-0176

2.25.2010
Health Canada has approved Gardasil to be used by boys and men in the prevention against
genital warts
Tonight 9:47PM
Channel Inc
MacMillan
Interview: None
Note: tag: Health Canada, Gardasil, boys, ages 9 to 26, genital warts, women, cervical
cancer, Ottawa, program, girls, h.p.v. virus
Log ID: 20100224T-0179
A new vaccine has been approved in the prevention of genital warts in men and boys
Tonight 9:17PM
Channel Inc
MacMillan
Interview: None
Note: tag: Gardasil, genital warts, men, boys, women, cervical cancer, Health Canada,
Ottawa, program, girls, h.p.v. virus
Log ID: 20100224T-0180
Date de publication : 2010-02-24 16:42
# Item: 211588
Région: Canada
Attachement(s): Télécharger
Titre du document: CTV-NEWSCHANNEL_8_46PM_FEB 23
Sommaire: A vaccine that protects women from cervical

cancer can now be used by boys and men to

2.25.2010
# Item: 211587
Région: Canada
Titre du document: CBC-RADIO1_UPTOSPEED_5_13PM_FEB 23
Sommaire: Boys and young men in Canada will now be able to

roll up their sleeves to get vaccinated for the virus
that causes cervical cancer in women
# Item: 211586
Région: Canada
Titre du document: CBC-RADIO1_WORLDATSIX_6_16PM_FEB 23
Sommaire: A controversial vaccine for girls has now also been

approved by Health Canada for boys Gardasil,
originally approved for females age 9 to 26, will
now target boys as well (to prevent genital warts
caused by the HPV
# Item: 211585
Région: Canada
Titre du document: CHCHNews-Gardasil
Sommaire: The vaccine manufacturer Merck says Health

Canada has approved an HPV vaccine for boys
and men aged 9-26 Gardasil has already been
approved for females in that age bracket to
prevent cervical cancer and genital warts. Tag:
Human Papilloma Virus, anal cancer in men, sexual
transmitted infection, Canadian

2.25.2010
Date de 2010-02-24 16:36
publication :
# Item: 211584
Région: Canada
Titre du document: GLOBALTV_GLOBALNATIONAL_5_47PM_FEBRUARY23
Sommaire: A vaccine that offers protection against the Human

Papilloma Virus in young women has now been
approved for use in young men

2.25.2010

SR Merck Gardasil

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

SR Merck Gardasil

Uploaded by

Copyright:

Available Formats

REVUE DE PRESSE / PRESS CLIPPINGS

Media Clippings · Special Edition

Media Clippings · Special Edition

Telegraph-Journal (NB) / Feb. 25 / D4 / HPV vaccine approved for males aged 9 to 26

The Canadian Press

© 2010 Telegraph-Journal (NB). All rights reserved.

Media Clippings · Special Edition

© 2010 The Daily News (Kamloops)

Media Clippings · Special Edition

The Canadian Press

© 2010 Times-Herald (Moose Jaw). All rights reserved.

Media Clippings · Special Edition

The Canadian Press

Media Clippings · Special Edition

Also published in: telegraphjournal.canadaeast.com; cjob.com; .640toronto.com

The Canadian Press

Media Clippings · Special Edition

Media Clippings · Special Edition

High level of shared HPV infections

Significant decline in genital warts

Media Clippings · Special Edition

● Cervical cancer (cancer of the lower end of the uterus or womb)

Media Clippings · Special Edition

With a link to:

Medbroadcast.blogspot.com / Feb. 24 / online / HPV vaccine to prevent genital warts

With a link to:

With a link to:

Bloggingcanadians.ca / Feb. 24 / online / Gardasil approved for males

With a link to: http://www.cbc.ca/health/story/2010/02/23/HPV-Gardasil-males.html

Media Clippings · Special Edition

Media Clippings · Special Edition

Gardasil is the vaccine against the HPV virus

Media Clippings · Special Edition

Media Clippings · Special Edition

Media Clippings · Special Edition

Date de publication : 2010-02-24 16:42

Sommaire: A vaccine that protects women from cervical

Media Clippings · Special Edition

Sommaire: Boys and young men in Canada will now be able to

Date de publication : 2010-02-24 16:38

Sommaire: A controversial vaccine for girls has now also been

Date de publication : 2010-02-24 16:37

Sommaire: The vaccine manufacturer Merck says Health

Media Clippings · Special Edition

Sommaire: A vaccine that offers protection against the Human

Media Clippings · Special Edition

You might also like